News
Interview: Nonclinical IVDs: Growing interest in a growing field
Some IVD companies are venturing into the very busy world of agricultural and nonclinical diagnostics.
Interview by Richard Park
Manufacturers of human IVD technologies have been contributing their skills and knowledge more and more to the nonclinical and agricultural diagnostic markets. Turning their attention to plant and animal testing can result in big rewards for these companies, but making this transition is not without its challenges.
To learn more about why IVD manufacturers are making the switch from human diagnostics and testing to agricultural and other nonclinical diagnostics, IVD Technology editor Richard Park spoke with Rocky Ganske, president and CEO of Axela Inc. (Toronto). In this interview, Ganske reflects on what 25 years in clinical diagnostics has taught him and discusses the main differences between his former field and the world of plant and animal diagnostics. He also offers his opinion on why life sciences companies are looking to nonclinical diagnostics and what the future holds for them.
Click the .pdf document below for full interview.
Additional documentation [PDF]